New Key Statistics Module, Z-Score and F-Score
OTCPK:GTHP Key Ratios
Market Cap $ M | 7.40 |
Enterprise Value $ M | 12.00 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 66.47 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.05 |
Beneish M-Score | -10.94 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.37 |
EV-to-EBITDA | -4.52 |
PEG | -- |
Shares Outstanding M | 55.69 |
Net Margin (%) | -3,685.37 |
Operating Margin % | -3,624.39 |
Pre-tax Margin (%) | -3,685.37 |
Quick Ratio | 0.11 |
Current Ratio | 0.23 |
ROA % (ttm) | -146.98 |
ROE % (ttm) | -- |
ROIC % (ttm) | -118.46 |
Dividend Yield % | -- |
Altman Z-Score | -150.48 |
GTHP Number of Guru Trades
GTHP Volume of Guru Trades
Gurus Latest Trades with OTCPK:GTHP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:GTHP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guided Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:GTHP
Total 0- 1